Fisher & Paykel Healthcare beats forecasts; Westpac NZ board “falls short”; The supply chain hits Gap right in the sales.

Recap

English - November 25, 2021 02:26 - 10 minutes - 14.1 MB - ★★★★★ - 2 ratings
Investing Business Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Serko announces a capital raise; Tesla’s $1.06 billion investment; CVS, Walgreens and Walmart linked to opioid crisis.

Next Episode: Casual Friday: What happened with the OCR? Green Cross Health delivers ‘positive’ performance; EROAD makes a net loss.

The medical equipment producer Fish & Paykel Healthcare (FPH) avoided expected drops in revenue and profit in their half year results. An independent reports outlines the “material shortcomings” of Westpac NZ’s (WBC) governance. Gap (GPS) is down $300 million in sales due to the ongoing supply chain disruptions.

www.sharesies.com

For more share market news, subscribe to Lunch Money, Sharesies’ bite-sized email update: https://www.sharesies.nz/lunch-money

Lunch Money: TradeWindow's direct-listing on the NZX with COO Andrew Balgarnie

If you'd like to get in touch, for any reason at all, email [email protected] or record a voice message: https://anchor.fm/sharesies2/message.

Investing involves risk. You aren’t guaranteed to make money, and you might lose the money you start with. We don’t provide personalised advice or recommendations. Any information we provide is general only and current at the time. For specific advice, speak to a licensed financial advice provider